RADLogics™ Adds AI Applications Modified for COVID-19 to Nuance Marketplace
Software supports CT and X-ray chest imaging.
RADLogics™ announced this week it is bringing additional software to the Nuance AI Marketplace, adding its artificial intelligence (AI)-powered medical imaging applications designed for the detection and quantification of COVID-19 findings.
The Nuance AI Marketplace is the first and largest one-stop portal that provides access to a myriad of AI diagnostic models. With this move, radiologists in more than 7,000 healthcare facilities nationwide can access the software applications.
These new medical imaging applications join RADLogic’s other patient triage and disease extent measurement tools. According to a company statement, these solutions have the capability of processing 1 million CT scans and 10 million X-rays daily through the RADLogic cloud-based platform.
Based on company information, the AI-powered software includes algorithms that can detect abnormalities on chest CTs and X-rays, as well as trigger automatic triage alerts to ensure a radiologist sees critical findings quickly. The company has modified its algorithms to detect lung abnormalities in patients who might have COVID-19. The tools, company officials said, are designed to provide quantitative analysis of CTs and X-rays, as well as provide a score than can help track findings over time.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?
June 19th 2025Emerging research shows that a multiple time-series deep learning model assessment of CT images provides 20 percent higher sensitivity than a delta radiomic model and 56 percent higher sensitivity than a clinical model for prognostic evaluation of ground-glass nodules.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
